A 64-year-female smoker presented with a prolonged history of altered behavior, personality changes, and seizures. Anti-HU and anti-RI antibodies were positive.
Magnetic resonance imaging demonstrated hyperintensity in the right hippocampal region (Fig. 1A) and corresponding increased radiotracer activity on positron emission tomography–computed tomography (PET-CT) (Fig. 1B, C).
FIGURE 1MRI brain (A) demonstrates FLAIR hyperintensity in the right hippocampal region. PET (B) and fused PET-CT (C) imaging showed corresponding increased radiotracer activity in the right hippocampal region—findings consistent with limbic encephalitis. MRI, magnetic resonance imaging; PET-CT, positron emission tomography–computed tomography.
This initial PET-CT was negative for malignancy. A follow-up PET-CT 6 months later showed increased uptake in a right hilar node (Fig. 2). This node was sampled with endobronchial ultrasound and fine needle aspirate confirmed small cell carcinoma.
FIGURE 2PET-CT demonstrates increased uptake in a single right hilar lymph node. This node was sampled with endobronchial ultrasound and cytology from a fine needle aspirate confirmed small-cell lung cancer. PET-CT, positron emission tomography–computed tomography.
Paraneoplastic limbic encephalitis is characterized by clinical presentation, presence of antineuronal antibodies, and imaging findings confirming involvement of the limbic system. Clinical symptoms and imaging abnormalities can predate the detection of malignancy by months to years.
1
Control and treatment of the primary tumor with chemotherapy or other antineoplastic treatments may result in a neurologic improvement. Immunosuppression with steroids, intravenous immune globulin, plasma exchange, and other immunotherapies may also be of value.
2
Symptomatic treatment should include seizure control with antiepileptic medications and medications to improve autonomic symptoms.
2
REFERENCES
- Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.Brain. 2000; 123: 1481-1494
- Current approaches to the treatment of paraneoplastic encephalitis.Ther Adv Neurol Disord. 2011; 4: 237-248
Article Info
Footnotes
Disclosure: The authors declare no financial disclosure or conflict of interest.
Identification
Copyright
© 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc.
User License
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
32400-X&id=gr1.jpg){kind=link}
32400-X&id=gr2.jpg){kind=link}